Materials and methods for treating coagulation disorders

Details Materials and methods for treating coagulation disorders Materials and methods for treating coagulation disorders

2006-12-05

2006-12-05

Owens, Amelia A. (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C549S305000

Reexamination Certificate

active

07145020

ABSTRACT:
This invention is drawn to compounds which are more easily metabolized by the metabolic drug detoxification systems. Particularly, warfarin analogs which have been designed to include esters within the structure of the compounds are taught. The invention teaches methods of reducing the toxicity of drugs comprising the introduction of ester groups into drugs during the synthesis of the drug. This invention is also drawn to methods of treating coagulation disorders comprising the administration of compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester containing warfarin, analogs are also taught.

REFERENCES:
patent: 3325515 (1967-06-01), Schmitt et al.
patent: 4748185 (1988-05-01), Entwistle et al.
patent: 5510375 (1996-04-01), Domagala et al.
patent: 5686486 (1997-11-01), Tomich et al.
patent: 5856525 (1999-01-01), Li et al.
patent: 2765579 (1999-01-01), None
patent: 1024383 (1966-03-01), None
patent: 1032253 (1966-06-01), None
Ciliag Ltd ‘Disubstituted nicotinamides’ CA 51:5827 (1957).
Zhao, H et al ‘Coumarin-based inhibitors of HIV integrase’ J. Med. Chem, 1997, 40, 242-249.
Poetzsch, B et al ‘Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assy’ CA 127:130379 (1997).
Ruan, Z et al ‘Study of sulfated beta-cyclodextrin chiral additive for enantiomeric separation by capillary electrophoresis’ CA 131:303449 (1999).
Avetisyan, AA et al ‘Synthisis and certain conversions of 3-(3,3-dichloroallyl)-4-hydroxycoumarin’ CA 128:48113 (1997).
Schmitt, J et al ‘Synthesis of a new anticoagulant’ CA 66:115544 (1967).
Masubuchi M et al ‘beta-(4-hydroxy-3-coumarinyl)-beta-substituted propionate’ CA 59:75249 (1963).
Morgan, LH et al ‘High throughput method for measuring physiochemical values using pH gradients and affinity chromatog. stationary phases’ CA 133:55643 (2000).
Sullivan, WR et al ‘hydroxycoumarins. II. the condesation of aldehydes with 4-hydroxycoumarins’ CA 38:5011 (1944).
Schmitt, J. et al. “Sur un nouvel st puissant anticoagulant de sythese,”Chemie Therapeutique(1966), vol. 1, pp. 301-304. (In French, translation also included).
Svetlik, Jan et al. “Expedient Synthesis of 3-Arylpropionic Acid Derivatives,”Synthetic Communications(1993), vol. 23, No. 5, pp. 631-640.
Thaisrivongs, Suvit et al. “Structure-based Design of Novel HIV Inhibitors: Carboxamide-Containing 4-Hydroxycoumarins and 4-Hydrozy-2-pyrones as Potent Nonpeptidic Inhibitors,”J. Med. Chem. (1995), vol. 38, pp. 3624-3637.
Zhao, H. et al. “Coumarin-based inhibitors of HIV Integrase,”J. Med. Chem. (1997), vol. 40, pp. 242-249.

Affiliated with

Also associated with

Rating

Materials and methods for treating coagulation disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for treating coagulation disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for treating coagulation disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3696185